In conclusion, we clarified the molecular mechanisms by which dinaciclib induces cell apoptosis and blocks the cell cycle through a CDK1‐involved pathway in Raji cells, which supported the view that dinaciclib has a potential value in the treatment of BL. Here, CDK1 is linked to Burkitt lymphoma.